SWA
ACAD icon

Sutton Wealth Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Sutton Wealth Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-373
Closed -$8.38K – 1126
2018
Q1 		$8.38K Hold
373
– – 0.01% 860
2017
Q4 		$11.2K Sell
373
-455
-55% -$14.6K 0.01% 748
2017
Q3 		$31.2K Hold
828
– – 0.02% 391
2017
Q2 		$23.1K Hold
828
– – 0.02% 471
2017
Q1 		$28.5K Hold
828
– – 0.02% 382
2016
Q4 		$23.9K Buy
+828
New +$21.9K 0.02% 443
2016
Q3 		– Sell
-221
Closed -$7.17K – 1045
2016
Q2 		$7.17K Buy
+221
New +$7.4K 0.01% 698

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return